Aprea Therapeutics

Aprea Therapeutics company information, Employees & Contact Information

Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. We exist to ensure that cancer doesn't interrupt life's possibilities and dreams. We do this through our unique approach to synthetic lethality that is revolutionizing the future of cancer treatment.

Company Details

Employees
13
Address
3805 Old Easton Rd, Doylestown,pennsylvania 18902,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Doylestown, Pennsylvania
Looking for a particular Aprea Therapeutics employee's phone or email?

Aprea Therapeutics Questions

News

Aprea Therapeutics Reports Promising Early Results for APR-1051 in Phase 1 Trial for Advanced Solid Tumors at AACR-NCI-EORTC Conference - Quiver Quantitative

Aprea Therapeutics Reports Promising Early Results for APR-1051 in Phase 1 Trial for Advanced Solid Tumors at AACR-NCI-EORTC Conference Quiver Quantitative

Aprea Therapeutics (NASDAQ: APRE) advances APR-1051; three of four stable at 100 mg - Stock Titan

Aprea Therapeutics (NASDAQ: APRE) advances APR-1051; three of four stable at 100 mg Stock Titan

Aprea Therapeutics Announces Presentations at - GlobeNewswire

Aprea Therapeutics Announces Presentations at GlobeNewswire

Aprea Therapeutics Reports Promising Preclinical and Initial Clinical Data for APR-1051 in HPV+ Head and Neck Cancers - Nasdaq

Aprea Therapeutics Reports Promising Preclinical and Initial Clinical Data for APR-1051 in HPV+ Head and Neck Cancers Nasdaq

Two abstracts accepted — Aprea to present APR-1051 & ATRN-119 posters at EORTC‑NCI‑AACR on Oct 24, 2025 - Stock Titan

Two abstracts accepted — Aprea to present APR-1051 & ATRN-119 posters at EORTC‑NCI‑AACR on Oct 24, 2025 Stock Titan

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center - GlobeNewswire

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center GlobeNewswire

Aprea Therapeutics Provides Update on Strong Patent Portfolio Supporting Oncology Therapeutics Development - Quiver Quantitative

Aprea Therapeutics Provides Update on Strong Patent Portfolio Supporting Oncology Therapeutics Development Quiver Quantitative

1,100 mg RP2D: Aprea Therapeutics shifts ATRN-119 to combination focus, pauses monotherapy enrollment - Stock Titan

1,100 mg RP2D: Aprea Therapeutics shifts ATRN-119 to combination focus, pauses monotherapy enrollment Stock Titan

Aprea Therapeutics Appoints Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer - citybiz

Aprea Therapeutics Appoints Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer citybiz

Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies - The Manila Times

Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies The Manila Times

Clinical-Stage Cancer Drug Developer Aprea Therapeutics to Present Latest Updates at Major Investment Conference - Stock Titan

Clinical-Stage Cancer Drug Developer Aprea Therapeutics to Present Latest Updates at Major Investment Conference Stock Titan

Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to Board - citybiz

Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to Board citybiz

Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference - The Manila Times

Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference The Manila Times

Aprea Therapeutics Announces Acquisition of Atrin - GlobeNewswire

Aprea Therapeutics Announces Acquisition of Atrin GlobeNewswire

Aprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of Directors - citybiz

Aprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of Directors citybiz

Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times

Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update The Manila Times

Aprea Therapeutics Announces Results of Primary Endpoint - GlobeNewswire

Aprea Therapeutics Announces Results of Primary Endpoint GlobeNewswire

Aprea Therapeutics Appoints John Hamill as Chief Financial Officer - citybiz

Aprea Therapeutics Appoints John Hamill as Chief Financial Officer citybiz

Magrolimab plus azacitidine vs physician’s choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study - ScienceDirect.com

Magrolimab plus azacitidine vs physician’s choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study ScienceDirect.com

John Aprea Dies: ‘The Godfather Part II’ & ‘Full House’ Actor Was 83 - Deadline

John Aprea Dies: ‘The Godfather Part II’ & ‘Full House’ Actor Was 83 Deadline

Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Stock Titan

Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Stock Titan

John Aprea, "The Godfather Part II" and "Full House" actor, dies at 83 - CBS News

John Aprea, "The Godfather Part II" and "Full House" actor, dies at 83 CBS News

Aprea Therapeutics Closes Out 2020 with Phase III Flop - BioSpace

Aprea Therapeutics Closes Out 2020 with Phase III Flop BioSpace

John Aprea, Known For ‘Full House’ and ‘Godfather Part II,’ Dies At 83 - TODAY.com

John Aprea, Known For ‘Full House’ and ‘Godfather Part II,’ Dies At 83 TODAY.com

Novel Strategies for Targeting the “Guardian of the Genome” Emerge - OncLive

Novel Strategies for Targeting the “Guardian of the Genome” Emerge OncLive

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis - Nature

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis Nature

John Aprea, ‘Godfather Part II’ and ‘Full House’ Actor, Dies at 83 (Published 2024) - The New York Times

John Aprea, ‘Godfather Part II’ and ‘Full House’ Actor, Dies at 83 (Published 2024) The New York Times

John Aprea, Actor in ‘The Godfather Part II’ and ‘Full House,’ Dies at 83 - The Hollywood Reporter

John Aprea, Actor in ‘The Godfather Part II’ and ‘Full House,’ Dies at 83 The Hollywood Reporter

With clinical holds lifted, Aprea embarks on 'show me' year for key cancer candidate - Fierce Biotech

With clinical holds lifted, Aprea embarks on 'show me' year for key cancer candidate Fierce Biotech

John Aprea, ‘The Godfather Part II’ Actor, Dies at 83 - TheWrap

John Aprea, ‘The Godfather Part II’ Actor, Dies at 83 TheWrap

John Aprea Dead: ‘Another World’ & ‘Full House’ Star Was 83 - TV Insider

John Aprea Dead: ‘Another World’ & ‘Full House’ Star Was 83 TV Insider

John Aprea, ‘Godfather Part II’ and ‘Full House’ Actor, Dies at 83 - Variety

John Aprea, ‘Godfather Part II’ and ‘Full House’ Actor, Dies at 83 Variety

'Godfather Part II' Star John Aprea Dead at 83 - TMZ

'Godfather Part II' Star John Aprea Dead at 83 TMZ

APREA conference: Rapidly expanding China REITs provide much needed liquidity - IPE Real Assets

APREA conference: Rapidly expanding China REITs provide much needed liquidity IPE Real Assets

Nicholas Aprea Jr. Obituary (2025) - Derby, CT - Edward F. Adzima Funeral Home - Derby - Legacy obituary

Nicholas Aprea Jr. Obituary (2025) - Derby, CT - Edward F. Adzima Funeral Home - Derby Legacy obituary

Joseph Guy Aprea Obituary (2025) - Kalkaska, MI - Kalkaska Funeral & Cremation Services - Legacy obituary

Joseph Guy Aprea Obituary (2025) - Kalkaska, MI - Kalkaska Funeral & Cremation Services Legacy obituary

Lancia Aprea 52 first look: a contemporary work of art - Motor Boat & Yachting

Lancia Aprea 52 first look: a contemporary work of art Motor Boat & Yachting

Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference - FinancialContent

Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference FinancialContent

48 John Aprea Photos & High-Res Pictures - Getty Images

48 John Aprea Photos & High-Res Pictures Getty Images

Teresa Apologizes to the Marcheses - bravotv.com

Teresa Apologizes to the Marcheses bravotv.com

Man Power 2024: Chef Rino Aprea - Boca Raton Magazine

Man Power 2024: Chef Rino Aprea Boca Raton Magazine

APRE Stock Price and Chart — NASDAQ:APRE - TradingView

APRE Stock Price and Chart — NASDAQ:APRE TradingView

Frank James Aprea Obituary (2022) - Norwalk, CT - Collins Funeral Home - Norwalk - Legacy obituary

Frank James Aprea Obituary (2022) - Norwalk, CT - Collins Funeral Home - Norwalk Legacy obituary

Denise Aprea Obituary (2011) - Canton, MA - Boston Globe - Legacy obituary

Denise Aprea Obituary (2011) - Canton, MA - Boston Globe Legacy obituary

Lancia Aprea 52: the XL cruising walkaround (up to 50 kn!). - Barche a Motore

Lancia Aprea 52: the XL cruising walkaround (up to 50 kn!). Barche a Motore

The Godfather Part II and Full House star John Aprea dies aged 83 - Metro.co.uk

The Godfather Part II and Full House star John Aprea dies aged 83 Metro.co.uk

Teresa: To Know Rino is to Love Him - bravotv.com

Teresa: To Know Rino is to Love Him bravotv.com

Teresa Aprea Net Worth 2024: How Much Money Does RHONJ Star Make? - Reality Tea

Teresa Aprea Net Worth 2024: How Much Money Does RHONJ Star Make? Reality Tea

Teresa Napolitano Aprea Net Worth - Celebrity Net Worth

Teresa Napolitano Aprea Net Worth Celebrity Net Worth

ARA Boss John Lim Elected Chairman of APREA - Mingtiandi

ARA Boss John Lim Elected Chairman of APREA Mingtiandi

ELIZABETH APREA Obituary (2009) - Sterling Heights, MI - The Detroit News - Legacy obituary

ELIZABETH APREA Obituary (2009) - Sterling Heights, MI - The Detroit News Legacy obituary

Rino Aprea Net Worth - Celebrity Net Worth

Rino Aprea Net Worth Celebrity Net Worth

Teresa Aprea stood by her husband - News Ghana

Teresa Aprea stood by her husband News Ghana

Top Aprea Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant